conjugated estrogens oral
Selected indexed studies
- The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms. (Postgrad Med, 2017) [PMID:28132583]
- The effects of oral medroxyprogesterone acetate combined with conjugated equine estrogens on inflammation in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. (Front Endocrinol (Lausanne), 2025) [PMID:41169467]
- Major adverse cardiovascular events risk in menopausal women treated with oral estradiol/micronized progesterone versus conjugated estrogens/medroxyprogesterone: a claims data analysis in the USA. (Climacteric, 2025) [PMID:40773298]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action. (2014) pubmed
- Pharmacokinetic Study of Conjugated Equine Estrogens in Healthy Chinese Postmenopausal Women Using a Parallel Two-Column LC-MS/MS Method. (2022) pubmed
- The effects of oral medroxyprogesterone acetate combined with conjugated equine estrogens on inflammation in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. (2025) pubmed
- Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy. (2025) pubmed
- The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms. (2017) pubmed
- Major adverse cardiovascular events risk in menopausal women treated with oral estradiol/micronized progesterone versus conjugated estrogens/medroxyprogesterone: a claims data analysis in the USA. (2025) pubmed
- Conjugated estrogens and hypercoagulability. (1975) pubmed
- Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice. (2023) pubmed
- Conjugated estrogens and breast cancer risk. (1999) pubmed
- Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. (1993) pubmed